Eradication of Helicobacter pylori: which patients, which drugs?

Helicobacter pylori, first detected in gastritis patients a decade ago, has now been shown to be the major cause of active chronic gastritis, and the evidence that it plays a major role in the pathophysiology of duodenal ulcers and possibly gastric ulcers is compelling. The infection is generally di...

Descripción completa

Detalles Bibliográficos
Publicado en:Physician Assistant Vol. 17; no. 4; pp. 65 - 72
Autores principales: DeCross AJ, Marshall BJ
Formato: CEU exam questions pictorial tables/charts Journal Article
Publicado: Lippincott Williams & Wilkins 1993 Apr
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=107401818&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 107401818
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        87507544
        15G
      jtl: Physician Assistant
      issn: 87507544
      maglogo: N
    pubinfo:
      dt: 1993 Apr
      vid: 17
      iid: 4
      pid: 5086
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        107401818
        107401818
        1995007207
        107401818
      ppf: 65
      ppct: 7
      formats:
      tig:
        atl: Eradication of Helicobacter pylori: which patients, which drugs?
      aug:
        au:
          DeCross AJ
          Marshall BJ
        affil: University of Virginia Health Sciences Center, Charlottesville
      sug:
        subj:
          Gastritis Etiology
          Gastritis Drug Therapy
          Duodenal Ulcer Etiology
          Duodenal Ulcer Drug Therapy
          Helicobacter Infections Drug Therapy
          Helicobacter Pylori
          Education, Continuing (Credit)
          Drug Therapy, Combination
          Antibiotics Administration and Dosage
      ab: Helicobacter pylori, first detected in gastritis patients a decade ago, has now been shown to be the major cause of active chronic gastritis, and the evidence that it plays a major role in the pathophysiology of duodenal ulcers and possibly gastric ulcers is compelling. The infection is generally diagnosed at the initial endoscopy by means of a rapid urease test, but it may be detected by serologic testing in patients not undergoing endoscopy. Treatment of the infection should be reserved for patients with duodenal ulcer disease that presents a significant management problem. The recommended therapy, commonly referred to as triple therapy, consists of bismuth subsalicylate, tetracycline, and metronidazole and has an 80% to 90% eradication success rate.
      pubtype: Periodical
      doctype:
        CEU
        exam questions
        pictorial
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N